Tyra Biosciences, Inc. TYRA Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s accounts payable?
- Tyra Biosciences, Inc. (TYRA) reported accounts payable of $3.64M in Q1 2026.
- How has Tyra Biosciences, Inc.'s accounts payable changed year-over-year?
- Tyra Biosciences, Inc.'s accounts payable increased by 45.7% year-over-year, from $2.5M to $3.64M.
- What is the long-term trend for Tyra Biosciences, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s accounts payable has grown at a 12.1% compound annual growth rate (CAGR), from $664K to $1.18M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.